NIPT (noninvasive prenatal testing) is a blood test used to screen for Down syndrome and a few other chromosomal conditions. You can have NIPT at 10 weeks of pregnancy or later. (You can also find out your baby's sex when you have this test.) ... NIPT is a screening test, not a diagnostic test.

Scope of the Report:

This report studies the Non-invasive Prenatal Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Non-invasive Prenatal Testing market by product type and applications/end industries.

The invasive methods of prenatal testing can cause miscarriages and are painful. This resulted in the development of non-invasive prenatal testing (NIPT) through advancements in genomic sciences and bioinformatic analytical tools. NIPT was introduced in the year 2011. This enabled physicians to carry out a safe screening and detection of chromosomal abnormalities in fetuses.

The global Non-invasive Prenatal Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Non-invasive Prenatal Testing.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

PerkinElmer

Roche

Sequenom

BGI Genomics

Illumina

LifeCodexx

Natera

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

First trimester

Second trimester

Third trimester

Post-term

Market Segment by Applications, can be divided into

Hospital

Laboratory

Table of Contents

1 Non-invasive Prenatal Testing Market Overview

1.1 Product Overview and Scope of Non-invasive Prenatal Testing

1.2 Classification of Non-invasive Prenatal Testing by Types

1.2.1 Global Non-invasive Prenatal Testing Revenue Comparison by Types (2017-2023)

1.2.2 Global Non-invasive Prenatal Testing Revenue Market Share by Types in 2017

1.2.3 First trimester

1.2.4 Second trimester

1.2.5 Third trimester

1.2.6 Post-term

1.3 Global Non-invasive Prenatal Testing Market by Application

1.3.1 Global Non-invasive Prenatal Testing Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospital

1.3.3 Laboratory

1.4 Global Non-invasive Prenatal Testing Market by Regions

1.4.1 Global Non-invasive Prenatal Testing Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Non-invasive Prenatal Testing Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Non-invasive Prenatal Testing Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Non-invasive Prenatal Testing Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Non-invasive Prenatal Testing Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Non-invasive Prenatal Testing Status and Prospect (2013-2023)

1.5 Global Market Size of Non-invasive Prenatal Testing (2013-2023)

2 Manufacturers Profiles

2.1 PerkinElmer

2.1.1 Business Overview

2.1.2 Non-invasive Prenatal Testing Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 PerkinElmer Non-invasive Prenatal Testing Revenue, Gross Margin and Market Share (2016-2017)

2.2 Roche

2.2.1 Business Overview

2.2.2 Non-invasive Prenatal Testing Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Roche Non-invasive Prenatal Testing Revenue, Gross Margin and Market Share (2016-2017)

2.3 Sequenom

2.3.1 Business Overview

2.3.2 Non-invasive Prenatal Testing Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Sequenom Non-invasive Prenatal Testing Revenue, Gross Margin and Market Share (2016-2017)

2.4 BGI Genomics

2.4.1 Business Overview

2.4.2 Non-invasive Prenatal Testing Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 BGI Genomics Non-invasive Prenatal Testing Revenue, Gross Margin and Market Share (2016-2017)

2.5 Illumina

2.5.1 Business Overview

2.5.2 Non-invasive Prenatal Testing Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Illumina Non-invasive Prenatal Testing Revenue, Gross Margin and Market Share (2016-2017)

2.6 LifeCodexx

2.6.1 Business Overview

2.6.2 Non-invasive Prenatal Testing Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 LifeCodexx Non-invasive Prenatal Testing Revenue, Gross Margin and Market Share (2016-2017)

2.7 Natera

2.7.1 Business Overview

2.7.2 Non-invasive Prenatal Testing Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Natera Non-invasive Prenatal Testing Revenue, Gross Margin and Market Share (2016-2017)

3 Global Non-invasive Prenatal Testing Market Competition, by Players

3.1 Global Non-invasive Prenatal Testing Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Non-invasive Prenatal Testing Players Market Share

3.2.2 Top 10 Non-invasive Prenatal Testing Players Market Share

3.3 Market Competition Trend

4 Global Non-invasive Prenatal Testing Market Size by Regions

4.1 Global Non-invasive Prenatal Testing Revenue and Market Share by Regions

4.2 North America Non-invasive Prenatal Testing Revenue and Growth Rate (2013-2018)

4.3 Europe Non-invasive Prenatal Testing Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Non-invasive Prenatal Testing Revenue and Growth Rate (2013-2018)

4.5 South America Non-invasive Prenatal Testing Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Non-invasive Prenatal Testing Revenue and Growth Rate (2013-2018)

5 North America Non-invasive Prenatal Testing Revenue by Countries

5.1 North America Non-invasive Prenatal Testing Revenue by Countries (2013-2018)

5.2 USA Non-invasive Prenatal Testing Revenue and Growth Rate (2013-2018)

5.3 Canada Non-invasive Prenatal Testing Revenue and Growth Rate (2013-2018)

5.4 Mexico Non-invasive Prenatal Testing Revenue and Growth Rate (2013-2018)

6 Europe Non-invasive Prenatal Testing Revenue by Countries

6.1 Europe Non-invasive Prenatal Testing Revenue by Countries (2013-2018)

6.2 Germany Non-invasive Prenatal Testing Revenue and Growth Rate (2013-2018)

6.3 UK Non-invasive Prenatal Testing Revenue and Growth Rate (2013-2018)

6.4 France Non-invasive Prenatal Testing Revenue and Growth Rate (2013-2018)

6.5 Russia Non-invasive Prenatal Testing Revenue and Growth Rate (2013-2018)

6.6 Italy Non-invasive Prenatal Testing Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Non-invasive Prenatal Testing Revenue by Countries

7.1 Asia-Pacific Non-invasive Prenatal Testing Revenue by Countries (2013-2018)

7.2 China Non-invasive Prenatal Testing Revenue and Growth Rate (2013-2018)

7.3 Japan Non-invasive Prenatal Testing Revenue and Growth Rate (2013-2018)

7.4 Korea Non-invasive Prenatal Testing Revenue and Growth Rate (2013-2018)

7.5 India Non-invasive Prenatal Testing Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Non-invasive Prenatal Testing Revenue and Growth Rate (2013-2018)

8 South America Non-invasive Prenatal Testing Revenue by Countries

8.1 South America Non-invasive Prenatal Testing Revenue by Countries (2013-2018)

8.2 Brazil Non-invasive Prenatal Testing Revenue and Growth Rate (2013-2018)

8.3 Argentina Non-invasive Prenatal Testing Revenue and Growth Rate (2013-2018)

8.4 Colombia Non-invasive Prenatal Testing Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Non-invasive Prenatal Testing by Countries

9.1 Middle East and Africa Non-invasive Prenatal Testing Revenue by Countries (2013-2018)

9.2 Saudi Arabia Non-invasive Prenatal Testing Revenue and Growth Rate (2013-2018)

9.3 UAE Non-invasive Prenatal Testing Revenue and Growth Rate (2013-2018)

9.4 Egypt Non-invasive Prenatal Testing Revenue and Growth Rate (2013-2018)

9.5 Nigeria Non-invasive Prenatal Testing Revenue and Growth Rate (2013-2018)

9.6 South Africa Non-invasive Prenatal Testing Revenue and Growth Rate (2013-2018)

10 Global Non-invasive Prenatal Testing Market Segment by Type

10.1 Global Non-invasive Prenatal Testing Revenue and Market Share by Type (2013-2018)

10.2 Global Non-invasive Prenatal Testing Market Forecast by Type (2018-2023)

10.3 First trimester Revenue Growth Rate (2013-2023)

10.4 Second trimester Revenue Growth Rate (2013-2023)

10.5 Third trimester Revenue Growth Rate (2013-2023)

10.6 Post-term Revenue Growth Rate (2013-2023)

11 Global Non-invasive Prenatal Testing Market Segment by Application

11.1 Global Non-invasive Prenatal Testing Revenue Market Share by Application (2013-2018)

11.2 Non-invasive Prenatal Testing Market Forecast by Application (2018-2023)

11.3 Hospital Revenue Growth (2013-2018)

11.4 Laboratory Revenue Growth (2013-2018)

12 Global Non-invasive Prenatal Testing Market Size Forecast (2018-2023)

12.1 Global Non-invasive Prenatal Testing Market Size Forecast (2018-2023)

12.2 Global Non-invasive Prenatal Testing Market Forecast by Regions (2018-2023)

12.3 North America Non-invasive Prenatal Testing Revenue Market Forecast (2018-2023)

12.4 Europe Non-invasive Prenatal Testing Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Non-invasive Prenatal Testing Revenue Market Forecast (2018-2023)

12.6 South America Non-invasive Prenatal Testing Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Non-invasive Prenatal Testing Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Non-invasive Prenatal Testing Picture

Table Product Specifications of Non-invasive Prenatal Testing

Table Global Non-invasive Prenatal Testing and Revenue (Million U